ARCHIVES

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

July 21, 1995

AACI Asks Funding Of Cancer Control Directors From Control Budget

February 11, 1983

In Brief: Over Half Of Ovarian Cancer Patients Staged Incorrectly; Senate Gets Funding Resolution

April 12, 1985

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

BSA Approves Concept For Ovarian Cancer SPORE Grant

June 26, 1998

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999